HLA-C and neoplasm: One of the mechanisms by which tumor cells avoid or escape immune surveillance is through loss of MHC expression on tumor cells and subsequent inadequate antigen presentation.51 Therefore, CAR T-cell construct has a single-chain variable fragment binding domain derived from a mAb that engages with the tumor antigen without the requirement for typical MHC restricted TCR signaling.